Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1360-0443.2010.03210.x | DOI Listing |
Drug Alcohol Rev
March 2024
Disease Elimination Program, Burnet Institute, Melbourne, Australia.
The National Naloxone Reference Group has played a key role in the development of take-home naloxone programs, policy and practice in Australia. In this commentary we detail the origins of the group, some of its main achievements since its inception and its future directions in light of the major policy changes around naloxone that have recently occurred in Australia.
View Article and Find Full Text PDFAm J Public Health
July 2023
Paul Dietze is with the National Drug Research Institute, Melbourne Office, Curtin University, and the Burnet Institute, Melbourne, Victoria, Australia.
Drug Alcohol Rev
July 2022
National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Australia.
People who inject drugs may be at higher risk of COVID-19 transmission and more severe negative health outcomes following COVID-19 infection. Early research on hypothetical COVID-19 vaccines suggests this population may be less likely to accept vaccination. This commentary extends this research by presenting vaccine intention data from Illicit Drug Reporting System interviews conducted in June-July 2021, in the early stages of vaccine rollout, with people in Australia who inject drugs (N = 888).
View Article and Find Full Text PDFAust N Z J Obstet Gynaecol
October 2020
Alcohol and Drugs Research Group, Centre for Population Health, Behaviours and Health Risks Program, Burnet Institute, Melbourne, Victoria, Australia.
Addiction
February 2021
Public Health Discipline, Burnet Institute, Melbourne, Victoria, Australia.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!